MaxCyte Inc (MXCT) — Cash Flow-to-Debt Ratio
Latest as of September 2025:
-0.22x
MaxCyte Inc (MXCT) has a Cash Flow-to-Debt Ratio of -0.22x as of September 2025, meaning its operating cash flow of $-7.46 Million could theoretically repay 0% of its total liabilities ($33.20 Million) in one year. See MXCT financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.22x
Operating CF / Total Liabilities
Operating Cash Flow
$-7.46 Million
USD
Total Liabilities
$33.20 Million
USD
Data as of
Sep 2025
Most recent filing
MaxCyte Inc Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for MaxCyte Inc across 13 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of MaxCyte Inc.
Annual Cash Flow-to-Debt Ratio for MaxCyte Inc (2012–2024)
Year-by-year debt coverage analysis for MaxCyte Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.83x | $-27.61 Million | $33.22 Million | ▼ -38.4% |
| 2023 | -0.60x | $-21.69 Million | $36.11 Million | ▼ -32.8% |
| 2022 | -0.45x | $-14.78 Million | $32.69 Million | ▲ +10.1% |
| 2021 | -0.50x | $-10.68 Million | $21.22 Million | ▼ -6.3% |
| 2020 | -0.47x | $-8.78 Million | $18.55 Million | ▲ +11.9% |
| 2019 | -0.54x | $-8.80 Million | $16.38 Million | ▲ +38.6% |
| 2018 | -0.87x | $-10.49 Million | $11.99 Million | ▼ -6.7% |
| 2017 | -0.82x | $-9.68 Million | $11.80 Million | ▼ -285.9% |
| 2016 | -0.21x | $-2.33 Million | $10.99 Million | ▼ -1016.4% |
| 2015 | -0.02x | $-180.50K | $9.48 Million | ▲ +92.1% |
| 2014 | -0.24x | $-1.93 Million | $7.95 Million | ▼ -75.8% |
| 2013 | -0.14x | $-557.80K | $4.05 Million | ▲ +77.7% |
| 2012 | -0.62x | $-2.13 Million | $3.43 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.